Vascular restenosis – striving for therapy

Author： Schiele Thomas M   Krötz Florian   Klauss Volker  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.11, 2004-11, pp. : 2221-2232

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Gene Therapy for Restenosis: Current Status

By Rutanen J.  

Drugs, Vol. 62, Iss. 11, 2002-01 ,pp. : 1575-1585

Adis International

Access to resources Recommend Favorite

Cilostazol: reduced restenosis vs standard therapy alone

By  

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Nitric oxide-based molecular strategies for restenosis therapy

By Lin Chia-En   Janero David R   Garvey David S  

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 5, 2005-05 ,pp. : 483-495

Informa Healthcare

Access to resources Recommend Favorite

Gene Therapy for Restenosis - What Now, What Next?

By  

Current Gene Therapy, Vol. 4, Iss. 2, 2004-06 ,pp. : 153-182

Bentham Science Publishers

Access to resources Recommend Favorite

Oligonucleotide-Based Molecular Therapy for Restenosis after Angioplasty

By  

Current Drug Targets, Vol. 4, Iss. 8, 2003-11 ,pp. : 613-618

Bentham Science Publishers

Access to resources Recommend Favorite